Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform


Year of Award:
2020
Status:
Complete
Award Type:
R44
Project Number:
CA250672
RFA Number:
PAR-18-303
PI/Project Leader:
WINTERS, IAN PAUL
Institution:
D2G ONCOLOGY, INC.